---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-248680"
form_type: "8-K"
ticker: "TNYA"
cik: "0001858848"
company_name: "Tenaya Therapeutics, Inc."
filed_at: "2026-05-29T21:04:54+00:00"
generated_at: "2026-05-29T21:08:04.102034+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Tenaya shareholders approve amended equity plan adding 6.5M shares, elect directors

## Summary
- Shareholders approved amended 2021 Equity Incentive Plan with one-time increase of 6,509,966 shares (~3% of outstanding).
- Annual evergreen cap removed; future yearly increase remains 4% of outstanding shares per fiscal year.
- Class II directors Amy Burroughs, Karah Parschauer, and Catherine Stehman-Breen elected with >86M votes each.
- Deloitte & Touche ratified as independent auditor for FY2026 with 135.6M votes for.
- Plan amendments also limit shares issuable as incentive stock options to 15M total.

## SEC filing metadata
- accession: 0001193125-26-248680
- form_type: 8-K
- ticker: TNYA
- cik: 0001858848
- company_name: Tenaya Therapeutics, Inc.
- filed_at: 2026-05-29T21:04:54+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1858848/000119312526248680/0001193125-26-248680-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1858848/000119312526248680/tnya-20260527.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-248680
- JSON: https://secwatch.observer/filing/0001193125-26-248680.json
- Plain text: https://secwatch.observer/filing/0001193125-26-248680.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.